Palatin Technologies (PTN) Change in Cash (2010 - 2026)
Palatin Technologies' (PTN) quarterly Change in Cash came in at -$4.3 million in Q1 2026, down 381.48% YoY from $1.5 million in Q1 2025, and down 132.69% on a QoQ basis from $13.2 million in Q4 2025.
Palatin Technologies (PTN) Change in Cash (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 17 years of Change in Cash data on file, last reported at -$4.3 million in Q1 2026.
- Quarterly Change in Cash fell 381.48% year-over-year to -$4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.6 million (up 201.94% YoY) and the FY2025 annual result came in at -$7.0 million, down 552.79% from the prior year.
- Change in Cash fell to -$4.3 million in Q1 2026, from $13.2 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $13.2 million in Q4 2025 to a low of -$11.6 million in Q2 2023.
- A 5-year average of -$2.2 million and a median of -$1.3 million in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash soared 43927.79% — and 2026, when it slumped 381.48%.
- Tracing PTN's Change in Cash over 5 years: stood at -$9036.0 in 2022, then soared by 43927.79% to $4.0 million in 2023, then slumped by 73.93% to $1.0 million in 2024, then soared by 1178.88% to $13.2 million in 2025, then plunged by 132.69% to -$4.3 million in 2026.
- The last three Change in Cash figures came in at -$4.3 million (Q1 2026), $13.2 million (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | -4.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.32 Mn |
| Dec 31, 2025 | 13.20 Mn |
| Sep 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | 44,203.00 |
| Mar 31, 2025 | -896,542.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | -7.14 Mn |
| Jun 30, 2024 | -486,692.00 |
| Mar 31, 2024 | 528,836.00 |
| Dec 31, 2023 | 3.96 Mn |
| Sep 30, 2023 | -2.46 Mn |
| Jun 30, 2023 | -11.64 Mn |
| Mar 31, 2023 | -1.55 Mn |
| Dec 31, 2022 | -9,036.00 |
| Sep 30, 2022 | -8.75 Mn |
| Jun 30, 2022 | -7.78 Mn |
| Mar 31, 2022 | -9.61 Mn |
| Dec 31, 2021 | -6.10 Mn |
| Sep 30, 2021 | -6.68 Mn |
| Jun 30, 2021 | -8.54 Mn |